Mr. Wibowo joined Broncus Technologies in March 2006. Prior to Broncus, Mr. Wibowo served as the President of Software at CompuMed, Inc. a healthcare informatics company providing tele-cardiology and skeletal health. Mr. Wibowo was a co-founder and served as President of Engineering at CompuRAD, Inc., a medical imaging company, from November 1991 to November 1997 and as President of Software Engineering at Lumisys Incorporated, a medical imaging company, from November 1997 to January 2000 where he was responsible for design and engineering of Lumisys’ software for its line of digitizers and CR devices.Mr. Wibowo holds a B.S. in Electrical Engineering from Oregon State University and a M.S. in Electrical Engineering from the University of Arizona.
Mr. Keast has been with Broncus since 1998 and has been a leader and contributor to nearly all products developed at Broncus as served as Principal R&D Engineer, Senior R&D Engineer and R&D Engineer. Prior to Broncus, Mr. Keast served as a Design Engineer at Stryker Endoscopy, designing and developing laparoscopic instruments such as the StrykeFlow 2, Suction Irrigator. Mr. Keast holds a B.S. in Mechanical Engineering from California Polytechnic State University in San Luis Obispo, CA.
Mr. Cornell has over 23 years of experience in medical device industry. He has held numerous sales and marketing positions at Abbott Vascular, Boston Scientific Corporation and United States Surgical Corporation. The last 14 years of Mr. Cornell’s career have been spent working in the Pulmonary space with start-up companies focused on the development and commercialization of a non-invasive treatment for emphysema. In this time, Mr. Cornell has set up a global sales channel for the commercialization of this technology, focused on developing a referral network for the treatment of the disease, assisted in the execution and completion of numerous clinical studies and hired and managed a direct sales force in 8 countries. Prior to joining Broncus Medical, Mr. Cornell most recently managed a large US salesforce focused on the treatment of inoperable liver cancer.